Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Characterization of biomolecular nanoconjugates by high-throughput delivery and spectroscopic difference.

Delong RK, Risor A, Kanomata M, Laymon A, Jones B, Zimmerman SD, Williams J, Witkowski C, Warner M, Ruff M, Garrad R, Fallon JK, Hickey AJ, Sedaghat-Herati R.

Nanomedicine (Lond). 2012 Dec;7(12):1851-62. doi: 10.2217/nnm.12.70. Epub 2012 Sep 3.

2.

Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.

Golkar N, Samani SM, Tamaddon AM.

Int J Pharm. 2016 Aug 20;510(1):30-41. doi: 10.1016/j.ijpharm.2016.06.026. Epub 2016 Jun 10.

PMID:
27291973
3.

Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.

Bartlett DW, Davis ME.

Bioconjug Chem. 2007 Mar-Apr;18(2):456-68. Epub 2007 Feb 28.

4.

Surface functionalized gold nanoparticles for drug delivery.

Cheng J, Gu YJ, Cheng SH, Wong WT.

J Biomed Nanotechnol. 2013 Aug;9(8):1362-9.

PMID:
23926802
5.

Characterization and performance of nucleic acid nanoparticles combined with protamine and gold.

DeLong RK, Akhtar U, Sallee M, Parker B, Barber S, Zhang J, Craig M, Garrad R, Hickey AJ, Engstrom E.

Biomaterials. 2009 Nov;30(32):6451-9. doi: 10.1016/j.biomaterials.2009.07.067. Epub 2009 Sep 1.

6.

PEGylated nanocarriers for systemic delivery.

Jain NK, Nahar M.

Methods Mol Biol. 2010;624:221-34. doi: 10.1007/978-1-60761-609-2_15.

PMID:
20217599
7.

Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes.

Chen AM, Taratula O, Wei D, Yen HI, Thomas T, Thomas TJ, Minko T, He H.

ACS Nano. 2010 Jul 27;4(7):3679-88. doi: 10.1021/nn901796n.

9.

Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells.

Medina SH, Chevliakov MV, Tiruchinapally G, Durmaz YY, Kuruvilla SP, Elsayed ME.

Biomaterials. 2013 Jun;34(19):4655-66. doi: 10.1016/j.biomaterials.2013.02.070. Epub 2013 Mar 22.

PMID:
23523429
10.

Native chemical ligation for conversion of sequence-defined oligomers into targeted pDNA and siRNA carriers.

Zhang CY, Kos P, Müller K, Schrimpf W, Troiber C, Lächelt U, Scholz C, Lamb DC, Wagner E.

J Control Release. 2014 Apr 28;180:42-50. doi: 10.1016/j.jconrel.2014.02.015. Epub 2014 Feb 22.

PMID:
24566255
11.

Stealth dendrimers for antiarrhythmic quinidine delivery.

Yang H, Lopina ST.

J Mater Sci Mater Med. 2007 Oct;18(10):2061-5. Epub 2007 Jun 9.

PMID:
17558476
12.

PEGylated Dendrimer-Doxorubicin Cojugates as pH-Sensitive Drug Delivery Systems: Synthesis and In Vitro Characterization.

She W, Pan D, Luo K, He B, Cheng G, Zhang C, Gu Z.

J Biomed Nanotechnol. 2015 Jun;11(6):964-78.

PMID:
26353586
13.

Low generation polyamine dendrimers bearing flexible tetraethylene glycol as nanocarriers for plasmids and siRNA.

Sharma R, Zhang I, Shiao TC, Pavan GM, Maysinger D, Roy R.

Nanoscale. 2016 Mar 7;8(9):5106-19. doi: 10.1039/c5nr06757j.

PMID:
26868181
14.

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

Zhu S, Hong M, Tang G, Qian L, Lin J, Jiang Y, Pei Y.

Biomaterials. 2010 Feb;31(6):1360-71. doi: 10.1016/j.biomaterials.2009.10.044. Epub 2009 Nov 2.

PMID:
19883938
15.

Dendrimer Nanovectors for SiRNA Delivery.

Liu X, Peng L.

Methods Mol Biol. 2016;1364:127-42. doi: 10.1007/978-1-4939-3112-5_11.

PMID:
26472447
16.

Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs.

Kojima C, Kono K, Maruyama K, Takagishi T.

Bioconjug Chem. 2000 Nov-Dec;11(6):910-7.

PMID:
11087341
17.

Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.

Singh P, Gupta U, Asthana A, Jain NK.

Bioconjug Chem. 2008 Nov 19;19(11):2239-52. doi: 10.1021/bc800125u.

PMID:
18950215
18.

Biotin Decorated Gold Nanoparticles for Targeted Delivery of a Smart-Linked Anticancer Active Copper Complex: In Vitro and In Vivo Studies.

Pramanik AK, Siddikuzzaman, Palanimuthu D, Somasundaram K, Samuelson AG.

Bioconjug Chem. 2016 Dec 21;27(12):2874-2885. doi: 10.1021/acs.bioconjchem.6b00537. Epub 2016 Dec 2.

PMID:
27998075
19.

Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.

Liu C, Liu X, Rocchi P, Qu F, Iovanna JL, Peng L.

Bioconjug Chem. 2014 Mar 19;25(3):521-32. doi: 10.1021/bc4005156. Epub 2014 Feb 11.

PMID:
24494983
20.

SiRNA delivery systems based on neutral cross-linked dendrimers.

Liu J, Zhou J, Luo Y.

Bioconjug Chem. 2012 Feb 15;23(2):174-83. doi: 10.1021/bc200433s. Epub 2012 Jan 31.

PMID:
22292572

Supplemental Content

Support Center